ASADORIAN RAFFI
Insider CIK 1628970 · AMRS Chief Financial Officer · ACRX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TLPH TALPHERA, INC. | F Tax w/h | 2026-04-02 | 2026-04-03 | 2,444 | $0.72 | $1.8K | 85,879 | SEC↗ |
| TLPH TALPHERA, INC. | F Tax w/h | 2026-02-14 | 2026-02-20 | 2,933 | $0.79 | $2.3K | 88,323 | SEC↗ |
| TLPH TALPHERA, INC. | A Award deriv | 2026-02-12 | 2026-02-20 | 260,000 | — | $0 | 260,000 | SEC↗ |
| TLPH TALPHERA, INC. | P Buy | 2026-02-12 | 2026-02-20 | 45,000 | $0.81 | $36.5K | 91,256 | SEC↗ |
| TLPH TALPHERA, INC. | F Tax w/h | 2026-02-10 | 2026-02-20 | 958 | $0.84 | $805 | 46,256 | SEC↗ |
| TLPH TALPHERA, INC. | A Award deriv | 2025-04-02 | 2025-04-03 | 80,000 | — | $0 | 80,000 | SEC↗ |
| TLPH TALPHERA, INC. | A Award | 2025-04-02 | 2025-04-03 | 15,000 | — | $0 | 47,214 | SEC↗ |
| TLPH TALPHERA, INC. | F Tax w/h | 2025-02-14 | 2025-02-18 | 3,245 | $0.67 | $2.2K | 32,214 | SEC↗ |
| TLPH TALPHERA, INC. | F Tax w/h | 2025-02-11 | 2025-02-12 | 1,060 | $0.62 | $657 | 35,459 | SEC↗ |
| TLPH TALPHERA, INC. | F Tax w/h | 2025-02-10 | 2025-02-12 | 1,059 | $0.63 | $667 | 36,519 | SEC↗ |
| TLPH TALPHERA, INC. | S Sale | 2024-12-02 | 2024-12-02 | 155 | $0.77 | $119 | 37,578 | SEC↗ |
| TLPH TALPHERA, INC. | F Tax w/h | 2024-03-03 | 2024-03-04 | 558 | $1.30 | $725 | 37,733 | SEC↗ |
| TLPH TALPHERA, INC. | A Award deriv | 2024-02-14 | 2024-02-27 | 108,000 | — | $0 | 108,000 | SEC↗ |
| TLPH TALPHERA, INC. | A Award | 2024-02-14 | 2024-02-27 | 18,000 | — | $0 | 38,291 | SEC↗ |
| TLPH TALPHERA, INC. | F Tax w/h | 2024-02-11 | 2024-02-13 | 895 | $1.10 | $985 | 20,291 | SEC↗ |
| TLPH TALPHERA, INC. | F Tax w/h | 2024-02-10 | 2024-02-13 | 895 | $1.10 | $985 | 21,186 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | F Tax w/h | 2023-03-03 | 2023-03-06 | 510 | $1.31 | $668 | 22,081 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | F Tax w/h | 2023-02-11 | 2023-02-14 | 873 | $1.68 | $1.5K | 22,591 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2023-02-10 | 2023-02-14 | 35,250 | — | $0 | 35,250 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award | 2023-02-10 | 2023-02-14 | 5,875 | — | $0 | 23,464 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | F Tax w/h | 2023-02-06 | 2023-02-08 | 617 | $2.02 | $1.2K | 17,589 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | F Tax w/h | 2022-03-03 | 2022-03-04 | 7,923 | $0.41 | $3.2K | 364,205 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2022-02-11 | 2022-02-14 | 235,000 | — | $0 | 235,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award | 2022-02-11 | 2022-02-14 | 117,500 | — | $0 | 376,015 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | F Tax w/h | 2022-02-11 | 2022-02-14 | 7,927 | $0.40 | $3.2K | 368,080 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | F Tax w/h | 2022-02-06 | 2022-02-07 | 9,391 | $0.43 | $4.0K | 258,515 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2021-03-03 | 2021-03-05 | 68,750 | — | $0 | 68,750 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2021-03-03 | 2021-03-05 | 137,500 | — | $0 | 137,500 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award | 2021-03-03 | 2021-03-05 | 68,750 | — | $0 | 260,597 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | F Tax w/h | 2021-02-11 | 2021-02-12 | 9,024 | $2.63 | $23.7K | 183,299 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | F Tax w/h | 2021-02-06 | 2021-02-09 | 9,414 | $2.59 | $24.4K | 192,323 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | F Tax w/h | 2020-02-11 | 2020-02-13 | 7,924 | $1.71 | $13.6K | 188,765 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2020-02-06 | 2020-02-07 | 137,500 | — | $0 | 137,500 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award | 2020-02-06 | 2020-02-07 | 68,750 | — | $0 | 196,689 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2019-11-02 | 2019-11-04 | 40,563 | — | $0 | 81,125 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2019-02-28 | 2019-03-04 | 3,647 | $2.81 | $10.2K | 124,397 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2019-02-11 | 2019-02-13 | 137,500 | — | $0 | 137,500 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award | 2019-02-11 | 2019-02-13 | 68,750 | — | $0 | 120,750 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2018-12-14 | 2018-12-17 | 5,000 | $2.78 | $13.9K | 52,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2018-11-13 | 2018-11-13 | 5,000 | $3.13 | $15.7K | 47,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2018-11-02 | 2018-11-05 | 40,562 | — | $0 | 40,562 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award | 2018-08-31 | 2018-09-05 | 10,000 | $1.49 | $14.9K | 42,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2018-08-06 | 2018-08-06 | 5,000 | $2.75 | $13.8K | 32,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2018-05-25 | 2018-05-29 | 5,000 | $3.18 | $15.9K | 27,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2018-01-22 | 2018-01-26 | 147,500 | — | $0 | 147,500 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2017-11-13 | 2017-11-14 | 5,000 | $1.94 | $9.7K | 12,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | P Buy | 2017-09-11 | 2017-09-11 | 7,000 | $3.24 | $22.7K | 7,000 | SEC↗ |
| ACRX ACELRX PHARMACEUTICALS INC | A Award deriv | 2017-08-16 | 2017-08-17 | 220,000 | — | $0 | 220,000 | SEC↗ |
| AMRS AMYRIS, INC. | F Tax w/h | 2017-01-01 | 2017-01-04 | 29,186 | $0.75 | $21.9K | 241,648 | SEC↗ |
| AMRS AMYRIS, INC. | A Award deriv | 2016-05-16 | 2016-05-18 | 200,000 | — | $0 | 200,000 | SEC↗ |
| AMRS AMYRIS, INC. | A Award | 2016-05-16 | 2016-05-18 | 100,000 | — | $0 | 270,834 | SEC↗ |
| AMRS AMYRIS, INC. | F Tax w/h | 2016-01-01 | 2016-01-05 | 29,166 | $1.62 | $47.2K | 170,834 | SEC↗ |
| AMRS AMYRIS, INC. | A Award deriv | 2015-01-20 | 2015-01-21 | 300,000 | — | $0 | 300,000 | SEC↗ |
| AMRS AMYRIS, INC. | A Award | 2015-01-20 | 2015-01-21 | 200,000 | — | $0 | 200,000 | SEC↗ |